Back to News
Feb 20, 2026 8:01 AM

J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push

Johnson & Johnson (NYSE:JNJ) is reportedly preparing for a potential sale of its orthopedics unit, DePuy Synthes, as it advances plans to separate the business.

In 2011, the medtech giant acquired DePuy Synthes for a massive $21.3 billion.

In October 2025, Johnson & Johnson said it plans to separate its Orthopedics business to enhance the strategic and operational focus.

Johnson & Johnson said it is targeting completion within 18 to 24 months.

Bloomberg noted that at the time, CFO Joseph Wolk said the company hadn’t yet decided how to enact the split but said it was preparing for the possibility of a spinoff, the most ...